Patents by Inventor Maureen Ryan

Maureen Ryan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERS
    Publication number: 20170233484
    Abstract: The invention provides humanized antibodies that specifically bind to BCMA. The antibodies are useful for treatment and diagnoses of various cancers and immune disorders as well as detecting BCMA.
    Type: Application
    Filed: February 16, 2017
    Publication date: August 17, 2017
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Django Sussman, Maureen Ryan, Lori Westendorf, Michael Feldhaus
  • Methods for screening antibodies
    Patent number: 9725500
    Abstract: The invention provides methods for making antibody conjugates for use in antibody screening assays and antibody conjugates produced by the claimed methods.
    Type: Grant
    Filed: February 28, 2011
    Date of Patent: August 8, 2017
    Assignee: Seattle Genetics, Inc.
    Inventors: Robert Lyon, Dennis Benjamin, Maureen Ryan
  • CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER
    Publication number: 20170204180
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically hind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Application
    Filed: January 20, 2017
    Publication date: July 20, 2017
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • CD33 antibodies and use of same to treat cancer
    Patent number: 9587019
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Grant
    Filed: May 15, 2013
    Date of Patent: March 7, 2017
    Assignee: SEATTLE GENETICS, INC.
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER
    Publication number: 20160376368
    Abstract: The invention provides antibodies that specifically bind to integrin ???6. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting ???6.
    Type: Application
    Filed: September 7, 2016
    Publication date: December 29, 2016
    Inventors: Maureen Ryan, Sussman Django
  • Antibodies to integrin AVB6 and use of same to treat cancer
    Patent number: 9493566
    Abstract: The invention provides antibodies that specifically bind to integrin ?v?6. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting ?v?6.
    Type: Grant
    Filed: February 14, 2013
    Date of Patent: November 15, 2016
    Assignee: Seattle Genetics, Inc.
    Inventors: Maureen Ryan, Sussman Django
  • ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER
    Publication number: 20160009806
    Abstract: The invention provides antibodies that specifically bind to integrin ?v?6. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting ?v?6.
    Type: Application
    Filed: February 14, 2013
    Publication date: January 14, 2016
    Inventors: Maureen Ryan, Sussman Django
  • Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive Cancers
    Publication number: 20160003847
    Abstract: The application provides methods of diagnosis, prognosis, prophylaxis and treatment of ovarian, pancreatic and other cancers using antibodies that specifically bind to denatured CD70.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 7, 2016
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Maureen Ryan, Maria Leia Smith
  • Detection and treatment of pancreatic, ovarian and other cancers
    Patent number: 9120854
    Abstract: The application provides methods of diagnosis, prognosis, prophylaxis and treatment of ovarian, pancreatic and other cancers using antibodies that specifically bind to denatured CD70.
    Type: Grant
    Filed: April 10, 2009
    Date of Patent: September 1, 2015
    Assignee: SEATTLE GENETICS, INC.
    Inventors: Maureen Ryan, Maria Leia Smith
  • CD33 ANTIBODIES AND USE OF SAME TO TREAT CANCER
    Publication number: 20150147316
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Application
    Filed: May 15, 2013
    Publication date: May 28, 2015
    Applicant: SEATTLE GENETICS, INC.
    Inventors: May Kung Sutherland, Maureen Ryan, Django Sussman, Patrick Burke, Scott Jeffrey
  • CD33 Antibodies And Use Of Same To Treat Cancer
    Publication number: 20130309223
    Abstract: The invention provides murine, chimeric, and humanized antibodies that specifically bind to CD33. The antibodies are useful for treatment and diagnoses of various cancers as well as detecting CD33.
    Type: Application
    Filed: March 14, 2013
    Publication date: November 21, 2013
    Inventors: MAY KUNG SUTHERLAND, MAUREEN RYAN, DJANGO SUSSMAN, PATRICK BURKE, SCOTT JEFFREY
  • METHODS FOR SCREENING ANTIBODIES
    Publication number: 20120322686
    Abstract: The invention provides methods for making antibody conjugates for use in antibody screening assays and antibody conjugates produced by the claimed methods.
    Type: Application
    Filed: February 28, 2011
    Publication date: December 20, 2012
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Robert Lyon, Dennis Benjamin, Maureen Ryan
  • DETECTION AND TREATMENT OF PANCREATIC, OVARIAN AND OTHER CANCERS
    Publication number: 20110300131
    Abstract: The application provides methods of diagnosis, prognosis, prophylaxis and treatment of ovarian, pancreatic and other cancers using antibodies that specifically bind to denatured CD70.
    Type: Application
    Filed: April 10, 2009
    Publication date: December 8, 2011
    Applicant: SEATTLE GENETICS, INC.
    Inventors: Maureen Ryan, Maria Leia Smith